Abstract
When histamine is applied topically to the eye it produces stinging and inflammation of the caruncle and bulbar and palpebral conjunctiva. This model has been employed in the present study to assess the ability of an oral antihistamine, astemizole, to attenuate the irritation and inflammatory signs. Astemizole 30 mg, taken orally once daily for 1 week, considerably lessened the stinging and significantly lowered the signs of inflammation caused by topically applied histamines.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- DANNENBERG T. B., FEINBERG S. M. The development of tolerance to antihistamines; a study of the quantitative inhibiting capacity of antihistamines on the skin and mucous membrane reaction to histamine and antigens. J Allergy. 1951 Jul;22(4):330–339. doi: 10.1016/0021-8707(51)90033-0. [DOI] [PubMed] [Google Scholar]
- Howarth P. H., Holgate S. T. Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hay fever. Thorax. 1984 Sep;39(9):668–672. doi: 10.1136/thx.39.9.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tuffin D. P., Feinberg J. G. Leucocyte infiltration into the conjunctiva following topical challenge with antigen, histamine, or compound 48/80. Monogr Allergy. 1977;12:213–215. [PubMed] [Google Scholar]